找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

SCIE期刊Endocrine Metabolic & Immune Disorders-Drug Targets 2024/2025影响因子:2.108 (ENDOCR METAB IMMUNE) (1871-5303). (PHARM

[复制链接]
楼主: misperceive
发表于 2025-3-25 03:55:06 | 显示全部楼层
发表于 2025-3-25 07:28:51 | 显示全部楼层
Submitted on: 05 February 2004. Revised on: 22 April 2004. Accepted on: 24 May 2004. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
发表于 2025-3-25 13:22:19 | 显示全部楼层
Submitted on: 19 December 2005. Revised on: 13 February 2006. Accepted on: 03 April 2006. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
发表于 2025-3-25 16:35:51 | 显示全部楼层
发表于 2025-3-25 20:59:06 | 显示全部楼层
发表于 2025-3-26 00:19:55 | 显示全部楼层
发表于 2025-3-26 06:20:58 | 显示全部楼层
发表于 2025-3-26 10:46:37 | 显示全部楼层
Submitted on: 29 August 2005. Revised on: 06 October 2005. Accepted on: 08 November 2005. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
发表于 2025-3-26 14:05:25 | 显示全部楼层
Submitted on: 07 June 2012. Revised on: 20 September 2012. Accepted on: 16 October 2012. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
发表于 2025-3-26 17:59:23 | 显示全部楼层
Submitted on: 04 May 2004. Revised on: 26 June 2004. Accepted on: 09 July 2004. ___________________Endocrine Metabolic & Immune Disorders-Drug Targets
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 11:07
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表